Both in Pharmaceuticals
Summit Therapeutics vs BioMarin Pharmaceuticals
Over the past year SMMT returned −7.5% and BMRN returned +8.8%; their daily moves had a correlation of 0.23.
SMMT −7.5% BMRN +8.8%Growth of $1, one year, split-adjusted
| Metric | SMMT | BMRN |
|---|---|---|
| Price | $16.17 | $57.13 |
| Market cap | $12.90B | $11.06B |
| Today | +2.34% | +2.64% |
| 1 month | −6.6% | +1.6% |
| 6 months | −9.4% | +4.6% |
| Year to date | −7.5% | −3.9% |
| 1 year | −11.3% | +8.1% |
| Revenue growth (YoY) | — | +19.9% |
| Gross margin | — | 79.5% |
| Net margin | — | 4.5% |
| P/E (TTM) | — | 151.5× |
| Price / sales | — | 3.2× |
| Net cash | $690.7M | -$3.31B |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 27.2% |
| Short % of float | 29.5% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).